financetom
Business
financetom
/
Business
/
BMO on The Day Ahead in Canada
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO on The Day Ahead in Canada
Feb 12, 2025 4:53 AM

07:30 AM EST, 02/12/2025 (MT Newswires) -- Canada's light data flow continues on Wednesday, noted Bank of Montreal (BMO).

Investors will hear from the Bank of Canada. The Summary of Deliberations from the BoC's Jan. 29 policy meeting will be published at 1:30 p.m. ET Wednesday and it will be scrutinized for two things, said the bank.

First, with the threat of United States tariffs still hanging over Canada, markets will be looking for any additional insight into the BoC's reaction function. The Monetary Policy Report provided some reasonable scenario analysis, but Governor Tiff Macklem left the timing and extent of any potential policy reaction somewhat ambiguous.

Still, the BoC opting to deliver a risk management 25bps cut suggests that the growth hit will be the first priority, though inflation risks will limit how far it's willing to ease, stated BMO.

The bank will also be looking for insight into whether the BoC's seemingly neutral tone will persist if U.S. tariffs don't materialize. Indeed, Governor Macklem sounded ready to pause absent tariffs to allow time to assess the data and the state of economic momentum into year-end.

While more information on the above would be ideal, given the tariff-driven uncertainty, the deliberations likely won't provide a clear narrative, pointed out the bank.

The Canadian dollar (CAD or loonie) starts the day right on the 70 U.S. cent mark (1.429/USD), with little response to the announced US tariffs on steel and aluminum imports, added BMO. The tariffs are slated to kick in on March 12 so, as in 2018, importers will likely get busy building inventories.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting
Montrose Environmental Acquires Canada-based Paragon Soil & Environmental Consulting
Jun 5, 2024
08:25 AM EDT, 06/05/2024 (MT Newswires) -- Montrose Environmental Group ( MEG ) said Wednesday that it has acquired Paragon Soil & Environmental Consulting, a Canada-based environmental consulting firm. Financial terms of the deal were not disclosed. Price: 43.54, Change: -0.43, Percent Change: -0.98 ...
Calibre Reports Additional Gold Mineralization at Valentine Gold Mine Complex in Newfoundland & Labrador
Calibre Reports Additional Gold Mineralization at Valentine Gold Mine Complex in Newfoundland & Labrador
Jun 5, 2024
08:26 AM EDT, 06/05/2024 (MT Newswires) -- Calibre (CXB.TO), which lost 4% yesterday, on Wednesday highlighted drill results from its 2024 exploration program within its 250-square-kilometer Valentine Gold Mine complex in Newfoundland & Labrador, Canada. Among the highlights, the company reported 2.25 g/t of gold over 15.30 meters estimated true width, including 24.68 g/t of gold over 0.85 meters estimated...
Deere to Cut Production, Salaried Jobs in Q3
Deere to Cut Production, Salaried Jobs in Q3
Jun 5, 2024
08:25 AM EDT, 06/05/2024 (MT Newswires) -- Deere (DE) will cut an unspecified number of production and salaried positions to meet its strategic priorities while reducing overlap and redundancy in roles and responsibilities, according to a Wednesday filing with the Securities and Exchange Commission. The layoffs are expected to take place in fiscal Q3, according to the filing. Deere said...
Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug
Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug
Jun 5, 2024
08:25 AM EDT, 06/05/2024 (MT Newswires) -- Mind Medicine's (MNMD) shares were down 9% in Wednesday's premarket activity, a day after advisers to the US Food and Drug Administration voted against Lykos Therapeutics' psychedelic drug. Lykos Therapeutics said late Tuesday that advisers to the US Food and Drug Administration have voted against its therapy based on the mind-altering drug midomafetamine,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved